Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Progyny Inc (NASDAQ: PGNY) closed at $32.40 down -2.00% from its previous closing price of $33.06. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 0.63 million shares were traded. PGNY stock price reached its highest trading level at $33.295 during the session, while it also had its lowest trading level at $32.34.
Ratios:
For a deeper understanding of Progyny Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.89. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.44. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $49.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $48.
On September 27, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $46.Canaccord Genuity initiated its Buy rating on September 27, 2023, with a $46 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 23 ’24 when Payson Norman sold 200 shares for $56.29 per share. The transaction valued at 11,258 led to the insider holds 580,656 shares of the business.
Livingston Mark S. sold 11,165 shares of PGNY for $419,979 on Apr 01 ’24. The CHIEF FINANCIAL OFFICER now owns 50,119 shares after completing the transaction at $37.62 per share. On Apr 01 ’24, another insider, Sturmer Michael E, who serves as the PRESIDENT of the company, sold 6,395 shares for $37.60 each. As a result, the insider received 240,452 and left with 384,553 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 3113974016 and an Enterprise Value of 2838573312. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 52.53, and their Forward P/E ratio for the next fiscal year is 32.61. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.87 while its Price-to-Book (P/B) ratio in mrq is 5.60. Its current Enterprise Value per Revenue stands at 2.608 whereas that against EBITDA is 44.033.
Stock Price History:
Over the past 52 weeks, PGNY has reached a high of $44.95, while it has fallen to a 52-week low of $29.44. The 50-Day Moving Average of the stock is -11.41%, while the 200-Day Moving Average is calculated to be -10.48%.
Shares Statistics:
For the past three months, PGNY has traded an average of 829.05K shares per day and 718260 over the past ten days. A total of 95.73M shares are outstanding, with a floating share count of 82.69M. Insiders hold about 14.31% of the company’s shares, while institutions hold 87.19% stake in the company. Shares short for PGNY as of 1711584000 were 6533094 with a Short Ratio of 7.88, compared to 1709164800 on 6483232. Therefore, it implies a Short% of Shares Outstanding of 6533094 and a Short% of Float of 8.2399994.
